HomeInsightsMarket Capitalization

Market Capitalization of Shukra Pharmaceuticals Ltd

Market Capitalization of Shukra Pharmaceuticals Ltd

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

4.6 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

Market Cap

₹ 257.91 crore

Last updated on: Nov 22, 2024

Key Highlights

  • The Market Cap of Shukra Pharmaceuticals Ltd is ₹ 257.91 crore as of 22 Nov 24 .
  • The Market Cap of Shukra Pharmaceuticals Ltd changed from ₹ 5.72 crore on March 2019 to ₹ 357.47 crore on March 2024 . This represents a CAGR of 99.21% over 6 years.
  • The Latest Trading Price of Shukra Pharmaceuticals Ltd is ₹ 58.89 as of 25 Nov 11:08 .
  • The dividend payouts of Shukra Pharmaceuticals Ltd changed from ₹ 0.5 to ₹ 1 over 6 quarters. This represents a CAGR of 58.74% .

Historical Market Cap of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Company Fundamentals for Shukra Pharmaceuticals Ltd

No data available

Image

Shukra Pharmaceuticals Ltd

NSE: SHUKRAPHARMA

Share Price

₹ 58.89

-0.01 (-0.02%)

stock direction

Last updated on: Nov 25, 2024

Market Price of Shukra Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Shukra Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202458.9
21 Nov 202458.28
19 Nov 202460.39
18 Nov 202462.68
14 Nov 202465.97
13 Nov 202464.93
12 Nov 202466.36
11 Nov 202469.15
08 Nov 202466.08
07 Nov 202467.87

SWOT Analysis Of Shukra Pharmaceuticals Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Shukra Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Shukra Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Shukra Pharmaceuticals Ltd

No data available

No data available

Historical P/E Ratio of Shukra Pharmaceuticals Ltd

No data available

* All values are in %

Historical Revenue of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Shukra Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Shukra Pharmaceuticals Ltd

No data available

* All values are in

About Shukra Pharmaceuticals Ltd

  • Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September, 2016.
  • The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele.
  • Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others.

Shukra Pharmaceuticals Ltd News Hub

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 ...

Read more

08 Nov 202417:22

News

Shukra Pharmaceuticals schedules board meeting

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 ...

Read more

24 Sep 202410:28

News

Shukra Pharmaceuticals to hold AGM

Shukra Pharmaceuticals announced that the 31th Annual General Meeting (AGM) of the company...

Read more

16 Sep 202410:13

News

Shukra Pharmaceuticals to discuss results

Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 ...

Read more

05 Aug 202410:57

News

Shukra Pharmaceuticals schedules EGM

Shukra Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compa...

Read more

31 Jul 202417:47

News

Board of Shukra Pharmaceuticals recommends final dividend

Shukra Pharmaceuticals announced that the Board of Directors of the Company at its meeting...

Read more

30 May 202412:16

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Shukra Pharmaceuticals Ltd Market Cap

What is the market cap of Shukra Pharmaceuticals Ltd?

As of November 25, 2024, Shukra Pharmaceuticals Ltd has a market capitalization of ₹257.91, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Shukra Pharmaceuticals Ltd's market capitalization?

Shukra Pharmaceuticals Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Shukra Pharmaceuticals Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Shukra Pharmaceuticals Ltd's market capitalization change?

Shukra Pharmaceuticals Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*